Exact Sciences is a biotech stock that is overpriced. It's time to sell We touched 3 times the resistance line of a rising wedge pattern, impulsive wave pattern, and RSI 71 weekly overbought zone, the Q2 doesn't seem good. A leg down to 60$ retesting 69$ which is the resistance line of a rising wedge dropping below 40$ and based on the Q2 announcement either...
Exact Sciences is a biotech stock showing high relative strength. Following a 50% jump in January, the stock is tightening with pullbacks getting shallower from left to right. This is a sign of seller digestion which we often see before a new breakout to the upside. EXAS is also finding support at key moving averages which appear to be holding up the stock. I...
Nice bat forming at a historical Ice line form way back when. Divergences are forming on other oscillators but Class A reversal divergence is on the RSI
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate,...
Exact Sciences Corp. is a molecular diagnostics company specialising in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer, in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other...
Strong support at $90. However, down trend line also is strong. Weakening momentum as confirmed by the MACD indicator. Likely to see the down trendline holding down prices. Will have to see which Demand Zone (green boxes) provides the support. If it doesn't and it breaks below the $90 support, then it might fall to $75-$80. Definitely don't want to see it fall...
SELL ENTRY: 96.50 USD TARGET: 71.71 USD (26% profit) STOP: 111.30 Exact Sciences Corporation is a cancer screening and diagnosis company. The company focuses on the early detection and prevention of several forms of cancer. 1.) The price broke within few days through 3 support areas! CAUTION! 2.) The profitability of business activity is a major weakness of the...
Eros STX Global Corp is a film production and distribution company. It distributes its film content across multiplex chains and stand-alone theatres and broadcasts television content via tie-ups with channels such as ZEE TV and Star TV. The company also has a digital presence through its website; www.erosnow.com and an independent channel on Youtube....
$EXAS is looking strong with a potentially good entrance for a gap up. BUY signal with 8 confirmations. Happy Trading, from CJ -- aka the greatest FURU. To find out more about The Ultimate Stock Indicator on Tradingview, please check my public profile.
The Bull Market is strong, but many stocks are extended and sentiment seems to be bullish. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 15 total stocks on this list. I also included 3 stocks with potential short squeeze opportunities. Many of these have IPO'd in the last few years and still have a...
EXAS was very strong and up over 20%. I am looking for it to retrace a bit to buy some.. Looks good if one is looking for something in health care science and research for your portfolio or you could simply swing trade. Please do not buy or sell any financial instrument or any other assets reading this post. This is strictly for education purposes only.
NASDAQ:EXAS shows potential continuation of uptrend to the next resistance $119.36
before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it...
Price created a nice inverted head and shoulders pattern aiming for the recent highs as long as price is above 100$ it's very bullish very nice upside potential here
The stock price broke down from its consolidation in September which dated back to early June. The price has recently bounced off a similar low creating a double-bottom pattern. While this double-bottom was created a bullish divergence formed between the price & RSI indicator. I would expect the price to continue rising & to eventually test the breakdown level...
EXAS gapped up and sold off trying a short 106/100 put spread 6 points wide Price was $2.28 max gain is $1.86/ $4.14 Max loss is $1.70 taking the loss in the the Oct 14-20 if it goes sour.